¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"binding capacity"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
11
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
antigen binding site
Ç׿ø °áÇÕ ºÎÀ§
¸é¿ª ±Û·ÎºÒ¸°ÀÇ 3Â÷ ±¸Á¶»ó H ¼â¿Í L ¼âÀÇ °¡º¯¿µ¿ª¿¡¼ ±¸¼ºµÇ¾î ÀÖ´Â Ç׿ø°ú °áÇÕÇÏ´Â ºÎÀ§.
binding activity
°áÇÕ È°¼º
binding displacement analysis
°áÇÕ º¯À§ ºÐ¼®
binding orbit
°áÇÕ ±Ëµµ
cellular retinoid acid-binding protein
¼¼Æ÷³» ·¹Æ¼³ëÀ̵å»ê °áÇÕ ´Ü¹é
corticosteroids binding globulin
ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå °áÇÕ ±Û·ÎºÒ¸°
human zona binding assay
»ç¶÷ Á¤ÀÚ Åõ¸í´ë ºÎÂø °Ë»ç
Langmuir expression in drug-antibody binding
¾à¹°-Ç×ü °áÇÕ¿¡¼ÀÇ ¶û¹¿¸£ Ç¥Çö
ligand receptor binding
¸®°£µå ¼ö¿ë±â °áÇÕ
penicillin binding protein
Æä´Ï½Ç¸° °áÇÕ ´Ü¹éÁú
plasma protein binding
Ç÷Àå ´Ü¹é °áÇÕ
ÀÌÀü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½